Ken Griffin's position in Regeneron Pharmaceuticals is currently worth $216 Million. That's 0.22% of their equity portfolio (83rd largest holding). The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Ken Griffin bought shares 54 more times and sold shares on 45 occasions. The stake costed the investor $118 Million, netting the investor a gain of 83% so far.